ArchimedesRX, LLC.

For many employers, managing the specialty drug benefit has become an exercise in frustration. Employers are absorbing runaway costs on specialty drugs that in too many cases, do not improve a patient’s length of life or provide other clinical value. In 2019, the average cost per-person for specialty drugs exceeded that for hospitalizations among people using at least one health care service. This pace of cost growth is simply not sustainable and threatens the financial viability of the entire h...